"Who decided to cut the phase 3 trial off early.It would be nearly completed by now anyway."
I seem to recall it was destined to run through 2010 and into 2011? May well be wrong.
"Why where only 6 people tested.After all we'de gone this far.They made it sound like they were recruiting hundreds.After-all they said about finding recruits around the world."
Where did you find the 6 people? That sounds wrong. Also, the latest announcement states that 246 patients were enrolled.
"They also bragged about how it would be a shoe-in for FDA approval once the phase 3 level was reached. "
FDA approval was part of it, and they discussed closing early with them. Let's see what they say in good time. I agree, this is possibly the biggest risk to Avexa. Also they closed it early to flush out the potential partners.
In my opinion, if we don't have a partner by the time FDA comes around to approving/rejecting, I'll be bitterly disappointed already.
Any comments? Apologies if I'm wrong on any of the above.
AVX Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
